DEVELOPMENT OF A NOVEL SEPARASE INHIBITOR, SEPIN-1, FOR BAREST CANCERS THERAPY

$920,813FY2015Department of the ArmyDOD

Baylor College Of Medicine, Houston TX

Investigators

View source on USAspending →